Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT01781715
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT01781715
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT01781715. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI
- Acronym
- ZES for STEMI
- Condition
- ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease
- Intervention (Device)
- Zotarolimus-eluting coronary stent
- Lead sponsor
- Russian Academy of Medical Sciences
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct01781715- Content hash
c7b4c2f45ba1a90d8adebe6ead2881b2efa7918be29c83f59fb4209bde8c4f58